Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: In vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice

American Journal of Clinical Nutrition

Volumn 66, Issue 2, 1997, Pages 267-275

  Fuhrman, Bianca ^b   Buch, Shlomi ^b   Vaya, Jacob ^b   Belinky, Paula A ^b   Coleman, Raymond ^b   Hayek, Tony ^b   Aviram, Michael ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Antioxidants; Atherosclerosis; Free radicals; Glabridin; Humans; Isoflavans; Licorice; Low density lipoprotein oxidation; Mice; Polyphenolic flavonoids

Indexed keywords

ALKADIENE; ANTIOXIDANT; APOLIPOPROTEIN E; COPPER ION; FREE RADICAL; GLABRIDIN; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; POLYPHENOL DERIVATIVE; SCAVENGER; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA ATHEROSCLEROSIS; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG CAPSULE; GLYCYRRHIZA; HEART; HUMAN; HUMAN EXPERIMENT; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; TRANSGENIC MOUSE;

ANIMALIA; GLYCYRRHIZA; MUS MUSCULUS;

EID: 0030793620     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/66.2.267     Document Type: Article

References (45)

1. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence. Lancet 1994;344:721-4.
2. Halliwell B, Cross CE, Gutteridge JMC. Free radicals, antioxidants and human disease: where are we now? J Lab Clin Med 1992;119:598-620.
3. Aviram M. Beyond cholesterol: modifications of lipoproteins and increased atherogenicity. In: Neri Serneri GG, Gensini GF, Abbate R, Prisco D, eds. Atherosclerosis, inflammation and thrombosis. Florence, Italy: Scientific Press, 1993:15-36.
4. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785-92.
5. Aviram M. Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis 1993;98:1-9.
6. Parthasarathy S, Printz DJ, Boyd D, Joy L, Steinberg D. Macrophage oxidation of low-density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis 1986;6:505-10.
7. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem 1983;52:223-61.
8. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL. Modification of human serum low density lipoprotein by oxidation - characterization and pathophysiological implications. Chem Phys Lipids 1987;45:315-36.
9. Heinecke JW, Bakeri L, Rosen H, Chait A. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J Clin Invest 1984;77:757-61.
10. Fuhrman B, Oiknine J, Aviram M. Iron induces lipid peroxidation in cultured macrophages increases their ability to oxidatively modify LDL and affect their secretory properties. Atherosclerosis 1994;111:65-78.
11. Lynch SM, Frei B. Mechanisms of copper and iron-dependent oxidative modification of human low density lipoprotein. J Lipid Res 1994;34:1745-53.
12. Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc Natl Acad Sci U S A 1991;88:1646-50.
13. Frei B, Gaziano JM. Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation. J Lipid Res 1993;34:2135-45.
14. Esterbauer H, Gebicki J, Puhl H, Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 1992;13:341-90.
15. Dieber-Rotheneder M, Puhl H, Waeg G, Striegl G, Esterbauer H. Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res 1991;32:1325-32.
16. Jialal I, Grundy SM. Effect of dietary supplementation with α-tocopherol on the oxidative modification of low density lipoprotein. J Lipid Res 1992;33:899-906.
17. Parthasarathy S, Yang SG, Witztum JL, Pittman RC, Steinberg D. Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest 1986;77:641-4.
18. Pentikainen MO, Lindstedt KA, Kovanen PT. Inhibition of the oxidative modification of LDL by Nitecapone. Arterioscler Thromb Vasc Biol 1995;15:740-7.
19. Breugnot C, Lliou JP, Privat S, Robin F, Vilaine JP, Lenaers A. In vitro and ex vivo inhibition of the modification of low-density lipoprotein by indapamide. J Cardiovasc Pharmacol 1992;20:340-7.
20. Parthasarathy S, Morales AJ, Murphy AA. Antioxidant: a new role for RU-486 and related compounds. J Clin Invest 1994;1990-5.
21. Lavy A, Ben Amotz A, Aviram M. Preferential inhibition of LDL oxidation by the all-trans isomer of β-carotene in comparison to the 9-cis β-carotene. Eur J Clin Chem Clin Biochem 1993;31:83-90.
22. Levy Y, Ben-Amotz A, Aviram M. Effect of dietary supplementation of different β-carotene isomers on lipoprotein oxidative modification. J Nutr Environ Med 1995;5:13-22.
23. van Acker AABE, van-den Berg DJ, Tromp MNJL, et al. Structural aspects of antioxidant activity of flavonoids. Free Radic Biol Med 1996;20:331-42.
24. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996;20:933-56.
25. Visioli F, Bellomo G, Montedoor GF, Galli C. Low density lipoprotein oxidation is inhibited in vitro by olive oil constitutents. Atherosclerosis 1995;117:25-32.
26. Aviram M, Kassem E. Dietary olive oil reduces the susceptibility of low density lipoprotein to lipid peroxidation and inhibits lipoprotein uptake by macrophages. Ann Nutr Metab 1993;37:75-84.
27. Fuhrman B, Lavy A, Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to undergo lipid peroxidation. Am J Clin Nutr 1995;61:549-54.
28. Furhman B, Aviram M. White wine reduces the susceptibility of low density lipoprotein to oxidation. Am J Clin Nutr 1996;63: 403-4(letter).
29. Gibson MR. Glycyrrhiza in old and new perspectives. Lloydia 1978;41:348-54.
30. Chandler RF. Licorice, more than just a flavour. Can Pharm J 1985;118:420-4.
31. Hikino H. Recent research on oriental medicinal plants. In: Wagner H, Hikino H, Farnsworth NR, eds. Economic and medicinal plant research. Vol 1. London: Academic Press. 1985:53-85.
32. Kiso Y, Tohkin M, Hikino H, Hattori M, Sakamoto T, Namba T. Mechanism of antihepatotoxic activity of glycyrrhizin, I: Effect on free radical generation and lipid peroxidation. Planta Medica 1984;50:298-302.
33. Demizu S, Kajiyama K, Takahashi K, et al. Antioxidant and antimicrobial constituents of licorice: isolation and structure elucidation of a new benzofuran derivative. Chem Pharm Bull 1988;36:3474-9.
34. Okada K, Tamura Y, Yamamoto M, et al. Identification of antimicrobial and antioxidant constituents from licorice of Russian and Xinjiang origin. Pharm Soc Japan 1989;37:2528-30.
35. Hayek T, Oiknine J, Brook JG, Aviram M. Increased plasma lipoprotein lipid peroxidation in apo E-deficient mice. Biochem Biophys Res Commun 1994;201:1567-74.
36. Aviram M. Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. Biochem Med 1983;30:111-8.
37. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
38. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302-10.
39. El-Saadani M, Esterbauer N, El-Sayed M, Goher M, Nassar AY, Jurgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J Lipid Res 1989;30:627-30.
40. Kahl R, Hildebrandt AG. Methodology for studying antioxidant activity and mechanisms of action of antioxidants. Food Chem Toxicol 1986;24:1007-14.
41. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989;6:67-75.
42. Blois MS. Antioxidant determination by the use of a stable free radical. Nature 1958;181:1199-200.
43. Miller HE. A simplified method for evaluation of antioxidants. J Am Oil Chem Soc 1971;48:91-3.
44. Saitoh T, Kinoshita T, Shibata S. New isoflavane and flavanone from licorice root. Chem Pharm Bull 1976;24:752-5.
45. Torel J, Cillard J, Cillard P. Antioxidant activity of flavonoids and reactivity with peroxy radicals. Phytochemistry 1986;25:383-7.